Polymyositis and dermatomyositis laboratory findings: Difference between revisions
Line 27: | Line 27: | ||
**Sarcoplasmic enzymes | **Sarcoplasmic enzymes | ||
**Myositis-specific autoantibodies | **Myositis-specific autoantibodies | ||
=== Sarcoplasmic enzymes === | === Sarcoplasmic enzymes === | ||
* Sarcoplasmic enzymes consistent with the diagnosis of polymyositis and dermatomyositis include:<ref name="BohanPeter1975">{{cite journal|last1=Bohan|first1=Anthony|last2=Peter|first2=James B.|title=Polymyositis and Dermatomyositis|journal=New England Journal of Medicine|volume=292|issue=8|year=1975|pages=403–407|issn=0028-4793|doi=10.1056/NEJM197502202920807}}</ref> | * Sarcoplasmic enzymes consistent with the diagnosis of polymyositis and dermatomyositis include:<ref name="BohanPeter1975">{{cite journal|last1=Bohan|first1=Anthony|last2=Peter|first2=James B.|title=Polymyositis and Dermatomyositis|journal=New England Journal of Medicine|volume=292|issue=8|year=1975|pages=403–407|issn=0028-4793|doi=10.1056/NEJM197502202920807}}</ref> |
Revision as of 20:34, 11 April 2018
Polymyositis and dermatomyositis Microchapters |
Differentiating Polymyositis and dermatomyositis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Polymyositis and dermatomyositis laboratory findings On the Web |
American Roentgen Ray Society Images of Polymyositis and dermatomyositis laboratory findings |
Polymyositis and dermatomyositis laboratory findings in the news |
Blogs on Polymyositis and dermatomyositis laboratory findings |
Risk calculators and risk factors for Polymyositis and dermatomyositis laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]
Overview
An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].
OR
Laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].
OR
[Test] is usually normal for patients with [disease name].
OR
Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].
OR
There are no diagnostic laboratory findings associated with [disease name].
Laboratory Findings
- Different laboratory tests may be used to diagnose polymyositis and dermatomyositis and exclude other myopathies which include:[1][2]
- Sarcoplasmic enzymes
- Myositis-specific autoantibodies
Sarcoplasmic enzymes
- Sarcoplasmic enzymes consistent with the diagnosis of polymyositis and dermatomyositis include:[3]
- Creatine phosphokinase
- Aldolase
- Transaminases
- Lactic dehydrogenase
Myositis-specific autoantibodies
Autoantibody | Association | Percentage |
---|---|---|
Histidyl-tRNA synthetase (anti-Jo-1) |
|
|
Chromodomain helicase DNA binding protein 4 (Mi-2) |
|
|
Signal recognition particle (anti-SRP) |
|
|
Alanyl-tRNA synthetase (PL-12) |
|
|
Transcriptional intermediary factor 1-gamma (TIF-1γ) |
|
|
Nuclear matrix protein (NXP-2) |
|
|
Anti-small ubiquitin-like modifier activating enzyme (anti-SAE) |
|
|
Anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) |
|
6% |
References
- ↑ Adler BL, Christopher-Stine L (February 2018). "Triggers of inflammatory myopathy: insights into pathogenesis". Discov Med. 25 (136): 75–83. PMID 29579414.
- ↑ Bodoki L, Nagy-Vincze M, Griger Z, Betteridge Z, Szöllősi L, Dankó K (December 2014). "Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort". Autoimmun Rev. 13 (12): 1211–9. doi:10.1016/j.autrev.2014.08.011. PMID 25182203.
- ↑ Bohan, Anthony; Peter, James B. (1975). "Polymyositis and Dermatomyositis". New England Journal of Medicine. 292 (8): 403–407. doi:10.1056/NEJM197502202920807. ISSN 0028-4793.